Your Product Innovation Begins Here: Booth 4555

Overview

EF-landing_page-optimized-Oct25

EffePharm will showcase innovative anti-aging solutions, including UthPeak™ reduced NMN (NMNH), the first Self-GRAS approved, US patent-pending reduced NMN. Backed by the largest and longest clinical trial, demonstrating an impressive 5-year age reversal.

In addition to NMNH, we will present other premium anti-aging offerings such as MitoAge™ Urolithin A, along with exciting new innovations in our weight management sector.

Discover our clinically proven liposomal products designed for enhanced absorption and efficacy, featuring LipoAvail™ liposomal NAD+ and LipoAvail™ liposomal glutathione.

This content is provided by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients-USA.com

Download Now

Related Topics

Healthy agingWeight management

Latest Content

Uthever NMN, effective solution to UV skin damage

Uthever NMN, effective solution to UV skin damage

Paid for and content provided by Effepharm Ltd

Several independent studies have been conducted to understand the relationship between NMN and aging, and to verify the potency of the anti-aging molecule NMN in reversing skin aging caused by UV radiation.

Related Resources

UthPeak™: World’s First Clinical Trial on NMNH

UthPeak™: World’s First Clinical Trial on NMNH

Content provided by Effepharm Ltd

Product Brochure

NMNH, the reduced form of NMN, is a potent NAD+ precursor. As the world’s first Self-GRAS approved NMNH, UthPeak™ has completed the world’s largest and longest human clinical trial.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.